Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
89 studies found for:    hepatitis c | Abbvie [Lead]
Show Display Options
Rank Status Study
1 Recruiting Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada
Condition: Chronic Hepatitis C
Intervention:
2 Recruiting The Effectiveness of ABT-450/r - Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland
Condition: Chronic Hepatitis C
Intervention:
3 Not yet recruiting Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2
Condition: Chronic Hepatitis C Virus
Intervention:
4 Active, not recruiting Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation - An Observational, Multi-Center Study
Conditions: Chronic Hepatitis C;   Genotype 1
Intervention: Drug: ABBVIE REGIMEN ± RBV
5 Active, not recruiting Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)
Condition: Chronic Hepatitis C
Intervention:
6 Recruiting Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
Condition: Chronic Hepatitis C Virus
Intervention:
7 Active, not recruiting Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
Condition: Chronic Hepatitis C Infection
Interventions: Drug: Ombitasvir/paritaprevir/ritonavir;   Drug: Dasabuvir;   Drug: Ribavirin
8 Active, not recruiting A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection
Conditions: Chronic Hepatitis C Virus;   Hepatitis C Virus
Interventions: Drug: ABT-493/ABT-530;   Drug: Sofosbuvir;   Drug: Ribavirin
9 Completed A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults
Conditions: Hepatitis C Infection;   Hepatitis C Virus
Interventions: Drug: Ombitasvir/Paritaprevir/Ritonavir;   Drug: dasabuvir
10 Active, not recruiting The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)
Condition: Hepatitis C Virus
Intervention: Drug: ABT-493/ABT-530
11 Recruiting The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects
Condition: Hepatitis C Virus
Intervention:
12 Recruiting A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ombitasvir;   Drug: paritaprevir;   Drug: ritonavir;   Drug: dasabuvir;   Drug: ribavirin
13 Active, not recruiting Effectiveness of Paritaprevir/r - Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania
Condition: Chronic Hepatitis C
Intervention:
14 Recruiting The Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in France
Condition: Chronic Hepatitis C
Intervention:
15 Not yet recruiting Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia
Condition: Chronic Hepatitis C
Intervention:
16 Active, not recruiting Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention:
17 Recruiting Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary - VERITAS
Condition: Chronic Hepatitis C
Intervention:
18 Completed
Has Results
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ABT-450/r/ABT-267, ABT-333;   Drug: Ribavirin;   Drug: Telaprevir;   Drug: Pegylated Interferon alpha 2-a (PegIFN)
19 Not yet recruiting A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
Condition: Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
Intervention: Drug: Glecaprevir/Pibrentasvir
20 Active, not recruiting A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
Condition: Chronic Hepatitis C Infection
Interventions: Drug: Ombitasvir/ABT-450/r;   Drug: Dasabuvir;   Drug: Sofosbuvir;   Drug: Ribavirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.